{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:56:17Z","timestamp":1793976977697,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:00:00Z","timestamp":1720310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:00:00Z","timestamp":1720310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Leukemia is a kind of hematological malignancy originating from bone marrow, which provides essential signals for initiation, progression, and recurrence of leukemia. However, how to specifically deliver drugs to the bone marrow remains elusive. Here, we develop biomimetic vesicles by infusing hematopoietic stem and progenitor cell (HSPC) membrane with liposomes (HSPC liposomes), which migrate to the bone marrow of leukemic mice via hyaluronic acid-CD44 axis. Moreover, the biomimetic vesicles exhibit superior binding affinity to leukemia cells through intercellular cell adhesion molecule-1 (ICAM-1)\/integrin \u03b22 (ITGB2) interaction. Further experiments validate that the vesicles carrying chemotherapy drug cytarabine (Ara-C@HSPC-Lipo) markedly inhibit proliferation, induce apoptosis and differentiation of leukemia cells, and decrease number of leukemia stem cells. Mechanically, RNA-seq reveals that Ara-C@HSPC-Lipo treatment induces apoptosis and differentiation and inhibits the oncogenic pathways. Finally, we verify that HSPC liposomes are safe in mice. This study provides a method for targeting bone marrow and treating leukemia.<\/jats:p>","DOI":"10.1038\/s41467-024-50021-9","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T21:01:34Z","timestamp":1720299694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Hematopoietic stem and progenitor cell membrane-coated vesicles for bone marrow-targeted leukaemia drug delivery"],"prefix":"10.1038","volume":"15","author":[{"given":"Jinxin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zebin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9197-3163","authenticated-orcid":false,"given":"Qiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5257-731X","authenticated-orcid":false,"given":"Wenchang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingli","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1052-7060","authenticated-orcid":false,"given":"Jianqing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5636-6704","authenticated-orcid":false,"given":"Pengxu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,7]]},"reference":[{"key":"50021_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2021. CA Cancer J. Clin. 71, 7\u201333 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"50021_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13045-017-0463-6","volume":"10","author":"C Saygin","year":"2017","unstructured":"Saygin, C. & Carraway, H. E. Emerging therapies for acute myeloid leukemia. J. Hematol. Oncol. 10, 93 (2017).","journal-title":"J. Hematol. Oncol."},{"key":"50021_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13045-020-00910-5","volume":"13","author":"R Huang","year":"2020","unstructured":"Huang, R. et al. Recent advances in CAR-T cell engineering. J. Hematol. Oncol. 13, 86 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"50021_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41551-019-0503-3","volume":"4","author":"NJ Shah","year":"2020","unstructured":"Shah, N. J. et al. A biomaterial-based vaccine eliciting durable tumour-specific responses against acute myeloid leukaemia. Nat. Biomed. Eng. 4, 40\u201351 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"50021_CR5","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/s41565-021-00980-7","volume":"16","author":"C Wang","year":"2021","unstructured":"Wang, C. et al. Ferritin-based targeted delivery of arsenic to diverse leukaemia types confers strong anti-leukaemia therapeutic effects. Nat. Nanotechnol. 16, 1413\u20131423 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"50021_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41551-020-00624-6","volume":"5","author":"X Xie","year":"2021","unstructured":"Xie, X. et al. Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen. Nat. Biomed. Eng. 5, 414\u2013428 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"50021_CR7","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.drudis.2018.02.001","volume":"23","author":"RJ Bose","year":"2018","unstructured":"Bose, R. J., Paulmurugan, R., Moon, J., Lee, S. H. & Park, H. Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics. Drug Discov. Today 23, 891\u2013899 (2018).","journal-title":"Drug Discov. Today"},{"key":"50021_CR8","doi-asserted-by":"publisher","first-page":"10049","DOI":"10.1021\/acsnano.6b04695","volume":"10","author":"Z Chen","year":"2016","unstructured":"Chen, Z. et al. Cancer cell membrane-biomimetic nanoparticles for homologous-targeting dual-modal imaging and photothermal therapy. ACS Nano 10, 10049\u201310057 (2016).","journal-title":"ACS Nano"},{"key":"50021_CR9","doi-asserted-by":"publisher","first-page":"12096","DOI":"10.1021\/acsnano.8b05292","volume":"12","author":"G Deng","year":"2018","unstructured":"Deng, G. et al. Cell-membrane immunotherapy based on natural killer cell membrane coated nanoparticles for the effective inhibition of primary and abscopal tumor growth. ACS Nano 12, 12096\u201312108 (2018).","journal-title":"ACS Nano"},{"key":"50021_CR10","doi-asserted-by":"publisher","first-page":"e1807591","DOI":"10.1002\/adma.201807591","volume":"31","author":"XC Jiang","year":"2019","unstructured":"Jiang, X. C. et al. Neural stem cells transfected with reactive oxygen species-responsive polyplexes for effective treatment of ischemic stroke. Adv. Mater. 31, e1807591 (2019).","journal-title":"Adv. Mater."},{"key":"50021_CR11","doi-asserted-by":"publisher","first-page":"1703197","DOI":"10.1002\/adfm.201703197","volume":"27","author":"H Tian","year":"2017","unstructured":"Tian, H. et al. Cancer cell membrane-biomimetic oxygen nanocarrier for breaking hypoxia-induced chemoresistance. Adv. Funct. Mater. 27, 1703197 (2017).","journal-title":"Adv. Funct. Mater."},{"key":"50021_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2023.101800","volume":"49","author":"H Wu","year":"2023","unstructured":"Wu, H. et al. Hybrid stem cell-derived bioresponsive vesicles for effective inflamed blood-brain barrier targeting delivery. Nano Today 49, 101800 (2023).","journal-title":"Nano Today"},{"key":"50021_CR13","doi-asserted-by":"publisher","first-page":"2006169","DOI":"10.1002\/adfm.202006169","volume":"30","author":"H Wu","year":"2020","unstructured":"Wu, H. et al. Engineering stem cell derived biomimetic vesicles for versatility and effective targeted delivery. Adv. Funct. Mater. 30, 2006169 (2020).","journal-title":"Adv. Funct. Mater."},{"key":"50021_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41568-019-0230-9","volume":"20","author":"D Vetrie","year":"2020","unstructured":"Vetrie, D., Helgason, G. V. & Copland, M. The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML. Nat. Rev. Cancer 20, 158\u2013173 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"50021_CR15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41568-020-0260-3","volume":"20","author":"M Yamashita","year":"2020","unstructured":"Yamashita, M., Dellorusso, P. V., Olson, O. C. & Passegue, E. Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis. Nat. Rev. Cancer 20, 365\u2013382 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"50021_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","volume":"20","author":"S Mendez-Ferrer","year":"2020","unstructured":"Mendez-Ferrer, S. et al. Bone marrow niches in haematological malignancies. Nat. Rev. Cancer 20, 285\u2013298 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"50021_CR17","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nri.2017.53","volume":"17","author":"GM Crane","year":"2017","unstructured":"Crane, G. M., Jeffery, E. & Morrison, S. J. Adult haematopoietic stem cell niches. Nat. Rev. Immunol. 17, 573\u2013590 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"50021_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41580-019-0103-9","volume":"20","author":"S Pinho","year":"2019","unstructured":"Pinho, S. & Frenette, P. S. Haematopoietic stem cell activity and interactions with the niche. Nat. Rev. Mol. Cell Biol. 20, 303\u2013320 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"50021_CR19","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.biomaterials.2013.11.011","volume":"35","author":"M Hanke","year":"2014","unstructured":"Hanke, M. et al. Differences between healthy hematopoietic progenitors and leukemia cells with respect to CD44 mediated rolling versus adherence behavior on hyaluronic acid coated surfaces. Biomaterials 35, 1411\u20131419 (2014).","journal-title":"Biomaterials"},{"key":"50021_CR20","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41556-022-00931-x","volume":"24","author":"YW Zhang","year":"2022","unstructured":"Zhang, Y. W. et al. Hyaluronic acid-GPRC5C signalling promotes dormancy in haematopoietic stem cells. Nat. Cell Biol. 24, 1038\u20131048 (2022).","journal-title":"Nat. Cell Biol."},{"key":"50021_CR21","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s12032-009-9257-1","volume":"27","author":"G Sundstrom","year":"2010","unstructured":"Sundstrom, G., Hultdin, M., Engstrom-Laurent, A. & Dahl, I. M. Bone marrow hyaluronan and reticulin in patients with malignant disorders. Med. Oncol. 27, 618\u2013623 (2010).","journal-title":"Med. Oncol."},{"key":"50021_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-09061-3","volume":"21","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. Aberrant expression of CD54 detected by flow cytometry is a characteristic of B-lymphoma cells in bone marrow specimens. BMC Cancer 21, 1315 (2021).","journal-title":"BMC Cancer"},{"key":"50021_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18932-4","volume":"8","author":"T Mandal","year":"2018","unstructured":"Mandal, T., Beck, M., Kirsten, N., Linden, M. & Buske, C. Targeting murine leukemic stem cells by antibody functionalized mesoporous silica nanoparticles. Sci. Rep. 8, 989 (2018).","journal-title":"Sci. Rep."},{"key":"50021_CR24","doi-asserted-by":"publisher","first-page":"18566","DOI":"10.1021\/acsami.7b04742","volume":"9","author":"M Beck","year":"2017","unstructured":"Beck, M., Mandal, T., Buske, C. & Linden, M. Serum protein adsorption enhances active leukemia stem cell targeting of mesoporous silica nanoparticles. ACS Appl. Mater. Interfaces 9, 18566\u201318574 (2017).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"50021_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.biomaterials.2017.11.029","volume":"155","author":"CF Mu","year":"2018","unstructured":"Mu, C. F. et al. Targeted drug delivery for tumor therapy inside the bone marrow. Biomaterials 155, 191\u2013202 (2018).","journal-title":"Biomaterials"},{"key":"50021_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nrrheum.2015.160","volume":"12","author":"MR Reagan","year":"2016","unstructured":"Reagan, M. R. & Rosen, C. J. Navigating the bone marrow niche: translational insights and cancer-driven dysfunction. Nat. Rev. Rheumatol. 12, 154\u2013168 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"50021_CR27","doi-asserted-by":"publisher","first-page":"2000309","DOI":"10.1002\/adfm.202000309","volume":"30","author":"X Dong","year":"2020","unstructured":"Dong, X. et al. Biomimetic, hypoxia\u2010responsive nanoparticles overcome residual chemoresistant leukemic cells with co\u2010targeting of therapy\u2010induced bone marrow niches. Adv. Funct. Mater. 30, 2000309 (2020).","journal-title":"Adv. Funct. Mater."},{"key":"50021_CR28","doi-asserted-by":"publisher","first-page":"eabc3013","DOI":"10.1126\/sciadv.abc3013","volume":"6","author":"T Ci","year":"2020","unstructured":"Ci, T. et al. Cryo-shocked cancer cells for targeted drug delivery and vaccination. Sci. Adv. 6, eabc3013 (2020).","journal-title":"Sci. Adv."},{"key":"50021_CR29","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41551-018-0310-2","volume":"2","author":"Q Hu","year":"2018","unstructured":"Hu, Q. et al. Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy. Nat. Biomed. Eng. 2, 831\u2013840 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"50021_CR30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/B978-0-12-800092-2.00006-X","volume":"123","author":"SK Khaldoyanidi","year":"2014","unstructured":"Khaldoyanidi, S. K., Goncharova, V., Mueller, B. & Schraufstatter, I. U. Hyaluronan in the healthy and malignant hematopoietic microenvironment. Adv. Cancer Res. 123, 149\u2013189 (2014).","journal-title":"Adv. Cancer Res."},{"key":"50021_CR31","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1182\/blood.V77.5.948.948","volume":"77","author":"S Arkin","year":"1991","unstructured":"Arkin, S., Naprstek, B., Guarini, L., Ferrone, S. & Lipton, J. M. Expression of intercellular adhesion molecule-1 (CD54) on hematopoietic progenitors. Blood 77, 948\u2013953 (1991).","journal-title":"Blood"},{"key":"50021_CR32","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1182\/blood.V82.10.3125.3125","volume":"82","author":"LJ Bendall","year":"1993","unstructured":"Bendall, L. J., Kortlepel, K. & Gottlieb, D. J. Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of beta-1 and beta-2 integrin mechanisms. Blood 82, 3125\u20133132 (1993).","journal-title":"Blood"},{"key":"50021_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3109\/10428199409049647","volume":"14","author":"JL Liesveld","year":"1994","unstructured":"Liesveld, J. L., Dipersio, J. F. & Abboud, C. N. Integrins and adhesive receptors in normal and leukemic CD34+ progenitor cells: potential regulatory checkpoints for cellular traffic. Leuk. Lymphoma 14, 19\u201328 (1994).","journal-title":"Leuk. Lymphoma"},{"key":"50021_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1182\/blood.V81.1.112.112","volume":"81","author":"JL Liesveld","year":"1993","unstructured":"Liesveld, J. L., Winslow, J. M., Frediani, K. E., Ryan, D. H. & Abboud, C. N. Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells. Blood 81, 112\u2013121 (1993).","journal-title":"Blood"},{"key":"50021_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22311-z","volume":"12","author":"B Bahmani","year":"2021","unstructured":"Bahmani, B. et al. Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors. Nat. Commun. 12, 1999 (2021).","journal-title":"Nat. Commun."},{"key":"50021_CR36","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1038\/s41565-018-0254-4","volume":"13","author":"Q Zhang","year":"2018","unstructured":"Zhang, Q. et al. Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat. Nanotechnol. 13, 1182\u20131190 (2018).","journal-title":"Nat. Nanotechnol."},{"key":"50021_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-4939-6591-5_2","volume":"1522","author":"H Zhang","year":"2016","unstructured":"Zhang, H. Thin-film hydration followed by extrusion method for liposome preparation. Liposomes 1522, 17\u201322 (2016).","journal-title":"Liposomes"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50021-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50021-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50021-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T21:03:01Z","timestamp":1720299781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-50021-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,7]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["50021"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-50021-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,7]]},"assertion":[{"value":"26 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5689"}}